In 2024, the forecasted re-import of heterocyclic compounds with an unfused imidazole ring to China is expected to be 7.52 thousand kilograms, marking a continuation of a downward trend from the actual level in 2023, which was slightly higher. The annual decrease is projected to continue at a modest rate: 1.73% from 2024 to 2025, 1.89% from 2025 to 2026, 1.79% from 2026 to 2027, and 1.83% from 2027 to 2028. The compound annual growth rate (CAGR) over this period is approximately -1.8%, indicating a gradual reduction over these years.

Future trends to watch for:

Potential shifts in China's domestic production capabilities for these chemical compounds, which could reduce dependency on re-imports.
Changes in global market supply chains or regulatory frameworks that might impact re-import volumes.
Technological advancements in chemical production that could influence import demand.